Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

After the outbreak of the coronavirus 2019-nCov (COVID-19) in Wuhan, China, in December 2019,[1] the disease rapidly became a global pandemic. Infection rates peaked and began to decline in some Asian countries by March 2020, but Europe and the US are now among the most affected regions.[2] Most COVID-19 infections are characterized by only mild symptoms of fever and cough; however, there is a high risk of severe pulmonary infection and death, in particular for the elderly and populations with comorbidities such as diabetes, hypertension and cardiopulmonary diseases.

Source: Radiotherapy and Oncology - April 5, 2020 Category: Radiology Authors: Matthias Guckenberger, Claus Belka, Andrea Bezjak, Jeffrey Bradley, Megan E. Daly, Dirk DeRuysscher, Rafal Dziadziuszko, Corinne Faivre-Finn, Michael Flentje, Elizabeth Gore, Kristin A. Higgins, Puneeth Iyengar, Brian D Kavanagh, Sameera Kumar, Cecile Le Source Type: research